NASDAQ:ALLO | Total Assets | Allogene Therapeutics, Inc.

Complete source-backed total assets history.

Available history
2017-11-29 to 2026-06-30
Data captured

Historical Total Assets

DateTotal assetsCurrent assetsCash and equivalentsCurrent securitiesReceivablesInventoryProperty, plant and equipmentOther noncurrent assets
2026-06-30$550.09M$340M$38.63M$67.38M$3.69M
2026-03-31$395.96M$273.29M$30.31M$70.02M$3.53M
2025-12-31$415.91M$257.75M$51.69M$72.84M$3.62M
2025-09-30$439.77M$260.72M$37.82M$75.9M$3.51M
2025-06-30$470.59M$282.66M$52.33M$78.86M$3.83M
2025-03-31$507.98M$291.58M$42.46M$82.99M$1.9M
2024-12-31$548.71M$303.39M$75.22M$86.06M$2.33M
2024-09-30$589.12M$304.42M$51.24M$88.99M$4.97M
2024-06-30$646.88M$457.12M$170.67M$92.08M$6.44M
2024-03-31$586.35M$395.36M$51.04M$95.93M$5.16M
2023-12-31$642.84M$459.12M$83.16M$99.48M$6.6M
2023-09-30$713.41M$473.45M$69.25M$102.83M$9.58M
2023-06-30$773.01M$502.1M$154.76M$106.39M$9.38M
2023-03-31$750.13M$481.47M$109.93M$109.85M$9.39M
2022-12-31$821.58M$528.82M$61.9M$112.84M$9.56M
2022-09-30$894.48M$569.06M$74.36M$114.44M$9.38M
2022-06-30$955.62M$513.03M$96.04M$117.22M$8.94M
2022-03-31$978.09M$469.74M$84.51M$120.2M$9.04M
2021-12-31$1.04B$471.32M$173.31M$283.99M$122.99M$5.82M
2021-09-30$1.08B$502.86M$190.02M$125.88M$6.16M
2021-06-30$1.13B$602.17M$223.5M$125.46M$5.83M
2021-03-31$1.18B$716.06M$236.87M$123.15M$6.28M
2020-12-31$1.23B$845.13M$183.35M$644.56M$118.84M$5.17M
2020-09-30$1.22B$854.06M$158.14M$102.65M$2.27M
2020-06-30$1.26B$909.58M$280.38M$84.61M$2.16M
2020-03-31$688.52M$504.41M$135.9M$357.03M$66.35M$4.68M
2019-12-31$717.8M$544.58M$175.13M$355.41M$56.45M$4.62M
2019-09-30$695.54M$509.76M$160.99M$340.25M$45.94M$3.11M
2019-06-30$734M$511.54M$112.58M$389.84M$35.82M$2.24M
2019-03-31$749.37M$476.63M$92.75M$373.39M$20.43M$432,000.00
2018-12-31$773.86M$467.98M$92.43M$366.95M$8.6M$244,000.00
2018-09-30$435.24M$247.35M$83.14M$161.08M$4.69M$2.31M
2018-06-30$143.93M
2018-03-31$5,000.00
2017-12-31$0.00
2017-11-29$0.00